Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Responding to an HIV Cluster or Outbreak: Who do you call? What do you do?
Model approaches for community partner engagement and coordination to support interventions for the mitigation of HIV outbreaks.Resource updated 04/07/2023
-
Addressing Substance Use Disorders (SUDs) as a Strategy to End the HIV Epidemic
Review of the impact of SUDs on HIV outcomes and effective evidence-based SUD interventions (Medication Assisted Treatment, Motivational Interviewing, and Contingency Management).Resource updated 03/15/2023
-
Finding and Using the Best Data Sources to Support EHE Strategies
Tips on linking to the best data sources and helping the EHE team integrate data management into implementation activities.Resource updated 04/07/2023
-
CDC on Updating HIV Criminalization Laws
-
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
Performance Measurement: Using Data to Achieve EHE Goals
The use of performance measures to help achieve EHE plan goals.Resource updated 04/07/2023
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Medical Monitoring Project 2019-2020 Data on HIV Care Access and Health Outcomes
In the U.S., almost all people with HIV have some type of health insurance coverage (pub
News Article updated on 08/09/2021 -
Reflections on COVID-19 Driven Telehealth Implementation in the RWHAP
The HRSA white page Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic offers lessons for future service delivery.Blog updated 01/23/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024
-
ESCALATE Glossary of Terms
The purpose of the ESCALATE training program is to facilitate transformative and relational change in Ryan White HIV/AIDS Programs (RWHAP) and the communities they serve. This is a Glossary of commonly used terms under in the ESCALATE capacity-building initiative.
Resource updated 05/14/2024
-
Transgender Women Engagement and Entry to Care (T.W.E.E.T): E2i
T.W.E.E.T. aims to engage transgender women in HIV care by combining weekly peer-based education and discussion groups, leadership training, community building, and the provision of supportive services. Three sites implemented T.W.E.E.T. as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients had improved outcomes across the HIV care continuum 12 months after enrollment in T.W.E.E.T.Resource from the RWHAP Best Practices Compilation updated on 02/09/2024
-
Imagine: Ending HIV. It’s Possible.
Imagine: Ending HIV. It’s Possible. is TAP-in's national campaign to inspire the HIV workforce to end the HIV epidemic by reducing the number of new HIV infections by 90% by 2030.Resource updated 04/25/2024
-
ESCALATE en español
ESCALATE capacita y empodera a participantes para reconocer y abordar el estigma del VIH dentro de cada nivel del programa Ryan White de VIH/SIDA (RWHAP, por sus siglas en inglés). ESCALATE contará con la participación de equipos de reducción del estigma (un mínimo de dos equipos participantes) dentro de las 57 jurisdicciones identificadas en la iniciativa Terminar con la epidemia de VIH: un plan para Estados Unidos (EHE, por sus siglas en inglés) con un enfoque particular en la reducción del estigma en las personas transgénero o de género no binario y hombres que tienen sexo con hombres. El programa también se enfocará en miembres de comunidades Negra/Africana Americana, latinx, comunidades india americanas y nativas de Alaska. NMAC trabaja en colaboración con Abt Associates, TRX Development y NORC de la Universidad de Chicago.Organization updated 03/28/2024
-
Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Review of fact sheet on different coverage and cost-sharing considerations for LAI ART across public and private payers.Blog updated 12/22/2022
-
ELEVATE: Principles of Harm Reduction in HIV Services
This webinar presented by ELEVATE NMAC Team and JSI will focus on promoting the application of Harm Reduction Principles among PWH employed in HIV Service Delivery System.Resource updated 02/28/2023
-
National Monitoring Standards and RWHAP Part B Manual Recipients
This HRSA technical assistance webinar provided a high level overview of updates made to both the National Monitoring Standards (NMS) and the Ryan White HIV/AIDS Program (RWHAP) Part B Manual. Release of the NMS is forthcoming.Resource updated 08/21/2023